Find us online

Latest News: ElevateBio to Present at the Morgan Stanley 18th Annual Global Healthcare Conference Read More

We provide the tools, time, and environment to innovate and accelerate development of life-saving therapies

Pioneering science

Together with scientific innovators and our strategic partners, we are rapidly building a diverse portfolio of companies advancing immunotherapies, regenerative medicine products, in vivo viral-based therapies, and other cutting-edge cell and gene therapies from preclinical to commercialization.

Explore our model

Advancing technology

We’re pioneering new methods to develop next generation, cell, viral, and regenerative therapies. We offer expertise to our portfolio companies and partners to accelerate the development of cell and gene therapies, from cGMP manufacturing suites to protein engineering, virology, and immunology labs.

Explore BaseCamp

what is basecamp?

BaseCamp provides a home for scientific founders to elevate their vision

ElevateBio BaseCamp – the heart of our operations – is a dedicated cell and gene therapy research, process development, and production center that addresses the primary obstacles in cell and gene therapy and regenerative medicine: integrated research, process development and manufacturing.

Explore Basecamp

Enabled By

Our portfolio companies benefit from our entrepreneurial and flexible culture. We accelerate early-stage companies through capital and expertise, allowing them to focus on science, research, and development.

Innovator in T-Cell Immunotherapies Established Out of Technology from the Baylor College of Medicine’s Center for Cell and Gene Therapy

learn more
Highpass Logo

Novel T Cell Immunotherapies Being Developed with Technology from The Fred Hutchinson Cancer Center

Learn More

News & Media

Stay up to date with news from our research, process development, cGMP manufacturing, clinical development, regulatory affairs, and commercial operations

Webcast Event
Morgan Stanley 18th Annual Global Healthcare Conference
Sep 16, 2020 at 5:00 PM EDT

Read More

August 25, 2020
ElevateBio to Present at the Morgan Stanley 18th Annual Global Healthcare Conference

Read More

May 26, 2020
ElevateBio to Present at the Jefferies Virtual Healthcare Conference

Read More

March 30, 2020
ElevateBio Closes $170 Million Series B Financing

Read More

March 26, 2020
European Medicines Agency Grants Orphan Drug Designation to AlloVir’s Viralym-M, an Allogeneic, Off-the-Shelf, Multi-Virus Specific T-Cell Therapy

Read More

March 5, 2020
ElevateBio Appoints Kareem Reda as Chief Business Officer

Read More


Privacy & Cookie Policy


200 Smith St
Suite 301
Waltham MA 02451


139 Main Street
Suite 500
Cambridge, MA 02142


Main Number

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from Youtube
Consent to display content from Vimeo
Google Maps
Consent to display content from Google